Almac Group

About:

Almac Group is a contract development and manufacturing firm offering integrated services to pharmaceutical and biotech companies globally.

Website: https://www.almacgroup.com

Twitter/X: almacgroup

Top Investors: Bill & Melinda Gates Foundation

Description:

Almac Group is a contract development and manufacturing organization that offers a wide range of services to pharmaceutical and biotech companies globally. These services include R&D, biomarker discovery and development, API manufacture, formulation development, clinical trial supply, IXRS technology (IVRS/IXRS), commercial-scale manufacture, as well as companion diagnostic development. Founded over 40 years ago and privately owned, Almac employs more than 4,500 staff. Its headquarters are in Craigavon, Northern Ireland, with additional operations in the UK, Ireland, the US (Pennsylvania, North Carolina, and California), and Asia (Singapore and Tokyo). Almac invests continually in its services, including biomarker and companion diagnostics, clinical trial data management, the clinical supply chain, and biocatalytic API manufacture.

Total Funding Amount:

$1M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Craigavon, Craigavon, United Kingdom

Founded Date:

2002-01-01

Contact Email:

info(AT)almacgroup.com

Founders:

Allen McClay

Number of Employees:

5001-10000

Last Funding Date:

2019-12-04

IPO Status:

Private

Industries:

© 2025 bioDAO.ai